Roelof Koster

The Netherlands Cancer Institute — Netherlands

Biochemistry, Genetics and Molecular Biology · Life Sciences

37h-index15.2kcitations120works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(36), RNA modifications and cancer(24), Genetic factors in colorectal cancer(13), Chromatin Remodeling and Cancer(12), Sarcoma Diagnosis and Treatment(10)

Publications73 total

Whole genome sequencing-based analysis of genetic predisposition to adult glioblastoma
npj Genomic Medicine·2025Open Access
Clinical application of tumour whole genome sequencing in routine molecular diagnostics for solid cancer patients
2025Open Access
Whole genome sequencing-based analysis of genetic predisposition to adult glioblastoma
2025Open Access
Optimized whole-genome sequencing workflow for tumor diagnostics in routine pathology practice
Nature Protocols·2023· 16 citedOpen Access
Impact of genetic counseling strategy on diagnostic yield and workload for genome-sequencing-based tumor diagnostics
Genetics in Medicine·2023· 6 citedOpen Access
1249P Whole genome sequencing-based cancer diagnostics in routine clinical practice: An interim analysis of two years of real-world data
Annals of Oncology·2023· 2 citedOpen Access
Impact of genetic counselling strategy on diagnostic yield and workload for genome sequencing-based tumour diagnostics
2023Open Access
Supplementary Table 5 from A Genome-Wide Scan Identifies Variants in <i>NFIB</i> Associated with Metastasis in Patients with Osteosarcoma
2023Open Access
Supplementary Table 3 from A Genome-Wide Scan Identifies Variants in <i>NFIB</i> Associated with Metastasis in Patients with Osteosarcoma
2023Open Access
Supplementary Table 6 from A Genome-Wide Scan Identifies Variants in <i>NFIB</i> Associated with Metastasis in Patients with Osteosarcoma
2023Open Access
Supplementary Table 4 from A Genome-Wide Scan Identifies Variants in <i>NFIB</i> Associated with Metastasis in Patients with Osteosarcoma
2023Open Access
Supplementary Table 2 from A Genome-Wide Scan Identifies Variants in <i>NFIB</i> Associated with Metastasis in Patients with Osteosarcoma
2023Open Access
Data from A Genome-Wide Scan Identifies Variants in <i>NFIB</i> Associated with Metastasis in Patients with Osteosarcoma
2023Open Access
Supplementary Figures 1 - 11 from A Genome-Wide Scan Identifies Variants in <i>NFIB</i> Associated with Metastasis in Patients with Osteosarcoma
2023Open Access
Supplementary Table 1 from A Genome-Wide Scan Identifies Variants in <i>NFIB</i> Associated with Metastasis in Patients with Osteosarcoma
2023Open Access
Supplementary Table 5 from A Genome-Wide Scan Identifies Variants in <i>NFIB</i> Associated with Metastasis in Patients with Osteosarcoma
2023Open Access
Supplementary Table 1 from A Genome-Wide Scan Identifies Variants in <i>NFIB</i> Associated with Metastasis in Patients with Osteosarcoma
2023Open Access
Supplementary Table 4 from A Genome-Wide Scan Identifies Variants in <i>NFIB</i> Associated with Metastasis in Patients with Osteosarcoma
2023Open Access
Supplementary Table 3 from A Genome-Wide Scan Identifies Variants in <i>NFIB</i> Associated with Metastasis in Patients with Osteosarcoma
2023Open Access
Supplementary Table 2 from A Genome-Wide Scan Identifies Variants in <i>NFIB</i> Associated with Metastasis in Patients with Osteosarcoma
2023Open Access
page 1 of 4Next →

Frequent Co-authors

Stephen J. Chanock(16), Kari G. Rabe(11), Logan G. Spector(9), Richard Görlick(9), Sílvia Regina Caminada de Toledo(9), Antônio Sérgio Petrilli(9), Ana Patiño‐García(9), Fernando Lecanda(9), Massimo Serra(9), Claudia Maria Hattinger(9), Piero Picci(9), Katia Scotlandi(9), Adrienne M. Flanagan(9), Roberto Tirabosco(9), Mandy L. Ballinger(9), David M. Thomas(9), Donald A. Barkauskas(9), Margaret A. Tucker(9), Sharon A. Savage(9), Nathan Pankratz(8)